Humacyte
HUMA
96 hedge funds and large institutions have $72.4M invested in Humacyte in 2024 Q1 according to their latest regulatory filings, with 18 funds opening new positions, 28 increasing their positions, 33 reducing their positions, and 10 closing their positions.
100% more funds holding in top 10
Funds holding in top 10: 1 → 2 (+1)
80% more first-time investments, than exits
New positions opened: 18 | Existing positions closed: 10
42% more capital invested
Capital invested by funds: $51.1M → $72.4M (+$21.3M)
9% more funds holding
Funds holding: 88 → 96 (+8)
2.55% more ownership
Funds ownership: 17.35% → 19.91% (+2.6%)
15% less repeat investments, than reductions
Existing positions increased: 28 | Existing positions reduced: 33
74% less call options, than puts
Call options by funds: $266K | Put options by funds: $1.02M
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
ACM
AIGH Capital Management
Baltimore,
Maryland
|
+$7.25M |
| 2 |
SCM
Sio Capital Management
New York
|
+$6.73M |
| 3 |
MIM
Monashee Investment Management
Boston,
Massachusetts
|
+$3.36M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
+$3.01M |
| 5 |
Capstone Investment Advisors
New York
|
+$1.05M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$3.47M |
| 2 |
Two Sigma Investments
New York
|
-$1.03M |
| 3 |
GCP
GSA Capital Partners
London,
United Kingdom
|
-$800K |
| 4 |
Morgan Stanley
New York
|
-$562K |
| 5 |
Marshall Wace
London,
United Kingdom
|
-$483K |
HUMA Hedge Fund Activity: Q1 2024 in Review
96 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Humacyte (HUMA) for Q1 2024, worth a combined $72.4M — up 42% from $51.1M a quarter earlier.
Buyers outnumbered sellers: 18 funds opened new HUMA positions and 10 closed out — a net gain of 8 holders — while 28 added to existing stakes and 33 trimmed.
The largest buyer was AIGH Capital Management, opening a new position worth an estimated $7.25M. The largest seller was Millennium Management, cutting an estimated $3.47M.
- 96 institutional investors held Humacyte (HUMA) as of Q1 2024, up from 88 in Q4 2023.
- Funds reported $72.4M of Humacyte stock for Q1 2024, up 42% quarter-over-quarter.
- 18 funds opened new Humacyte positions in Q1 2024 and 10 closed out, a net change of +8 holders.
- The largest Humacyte buyer in Q1 2024 was AIGH Capital Management, an estimated $7.25M added.
- The largest Humacyte seller in Q1 2024 was Millennium Management, an estimated $3.47M sold.
Based on aggregated 13F filings for Q1 2024.